Leading Airbus China: Race Against Boeing
Former Chairman and President at Airbus China
inpractise.com/articles/airbus-china-against-boeing
Why is this interview interesting?
- Outlook on domestic and international travel demand
- Strategic options for airlines and lessors during crisis
- Impact on Airbus and Boeing cutting production post-crisis
- How the A320 gained market share versus 737 in the last 20 years
- Biggest lessons from running Airbus China
Leading Airbus China: Race Against Boeing(April 21, 2020)
Laurence Barron
Former Chairman and President at Airbus China
Laurence was the President and Chairman of Airbus China from 2004 - 2017 where he led the business to grow from producing 40 to over 160 aircraft per year and grew revenue to over €20bn in China. He joined Airbus in 1982 in aircraft finance where he ran customer finance for 10 years and then asset management for a decade. Laurence spent a total of over 25 years in aircraft financing and leasing before moving to lead Airbus China.
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Related Content
Airbus China Chairman: Building Teams
Former Chairman and President at Airbus China
Airbus China Chairman: Be Opportunistic
Former Chairman and President at Airbus China
COVID-19 Impact on Airbus & Boeing
Former Chairman and President at Airbus China
COVID-19: Oversupply of Aircraft
Former Chairman and President at Airbus China
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2023 IP 1 Ltd. All rights reserved.